Clinical Trials Browser

Phase 1 × Hodgkin Disease × Dacarbazine × Clear all

NCT01056679 2018-03-22

AVD-Rev

Phase 1 Completed

Hodgkin Disease

NCT01060904 2014-12-18

A Phase 1 Study of Brentuximab Vedotin Combined With Multi-Agent Chemotherapy for Hodgkin Lymphoma

Phase 1 Completed

Hematologic Diseases, Hodgkin Disease, Lymphoma